130532-55-7

Upstream product

• 126587-36-8 (4S)-1,1-dimethylethyl 4-<(Z)-3'-methoxy-3'-oxo-1'-propenyl>-2,2-dimethyl-3-oxazolidinecarboxylate 

Downstream Products

• 846040-61-7 (S)-4-((Z)-3-Benzenesulfonyl-propenyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 1026553-88-7 (Z)-(S)-5-Benzenesulfonyl-2-(benzhydrylidene-amino)-pent-3-en-1-ol 
• 846040-65-1 ((Z)-(S)-4-Benzenesulfonyl-1-iodomethyl-but-2-enyl)-benzhydrylidene-amine 
• 114376-26-0 L-2-amino-5-phosphono-3-cis-pentenoic acid 
• 114301-25-6 L-arginyl-5-phosphono-L-cis-3,4-didehydronorvaline 
• 1449748-54-2 C₁₉H₂₇N₂O₈P*C₂HF₃O₂ 
• 1449748-55-3 C₂₇H₄₀N₃O₁₁P 
• 954142-49-5 tert-butyl (4S)-4-[(1Z)-3-{[2-(diphenylphosphanyl)benzoyl]oxy}prop-1-enyl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate 

Relevant academic research and scientific papers

SYNTHESES OF 3'-SUBSTITUTED-2-(CARBOXYCYCLOPROPYL)GLYCINES VIA INTRAMOLECULAR CYCLOPROPANATION. THE FOLDED FORM OF L-GLUTAMATE ACTIVATES THE NON-NMDA RECEPTOR SUBTYPE

Four stereoisomers of 3'-methoxymethyl-L-2-(carboxycyclopropyl)glycines, conformationally constrained analogues of L-glutamate, were synthesized in a stereoselective manner from D-serinal derivative.Selective activation of either the NMDA or Non-NMDA receptor by these isomers was observed.